A preliminary survey of rheumatologists on the management of late-onset rheumatoid arthritis in Japan

Objectives We investigated the current perspectives regarding the management of late-onset rheumatoid arthritis (LORA) among rheumatologists in clinical practice. Methods This study was performed in October 2021, and included 65 rheumatologists certified by the Japan College of Rheumatology, who wer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal Medicine 2024, pp.3288-23
Hauptverfasser: Takanashi, Satoshi, Kaneko, Yuko, Kawahito, Yutaka, Kida, Takashi, Sugihara, Takahiko, Kojima, Toshihisa, Harada, Ryozo, Ishitoku, Michinori, Hirata, Shintaro, Hashimoto, Motomu, Hidaka, Toshihiko, Abe, Asami, Ishikawa, Hajime, Ito, Hiromu, Kishimoto, Mitsumasa, Matsui, Kazuo, Matsui, Toshihiro, Matsushita, Isao, Onishi, Akira, Morinobu, Akio, Nishida, Keiichiro, Asai, Shuji, Tanaka, Eiichi, Harigai, Masayoshi, Kojima, Masayo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives We investigated the current perspectives regarding the management of late-onset rheumatoid arthritis (LORA) among rheumatologists in clinical practice. Methods This study was performed in October 2021, and included 65 rheumatologists certified by the Japan College of Rheumatology, who were administered questionnaires (including multiple choice and descriptive formulae) regarding the management of LORA. We aggregated and analyzed the responses. Results All 65 rheumatologists responded to the survey; 47 (72%) answered that >50% of newly diagnosed patients were aged ≥65 years, 42 (65%) answered that achievement of remission or low disease activity was the treatment goal, and 40 (62%) considered patient safety to be the highest priority. Most rheumatologists are concerned about the management of conditions other than RA, such as comorbidities, financial constraints, and life circumstances that interfere with standard or recommended treatment implementation. Conclusion This preliminary survey highlighted various rheumatologists' perspectives regarding the management of LORA.
ISSN:0918-2918
1349-7235
1349-7235
DOI:10.2169/internalmedicine.3288-23